Home / Letter From The Editor / May 26, 2020

May 26, 2020

May 26, 2020
 

Over the past 5 years all of the SGLT-2 inhibitors have gotten various indications for cardiovascular protection. Now it appears that a drug used for Acute Coronary Syndrome can have very positive benefits in preventing and reversing diabetes. Check out this week’s feature from Chardae Whitner, 2020 PharmD. Candidate, Lake Erie College of Osteopathic Medicine, on the use of dalcetrapib and its effects on diabetes.

*****************************

 

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief